Bishop's Stortford, United Kingdom

Laramie Mary Gaster

This inventor holds 48 USPTO granted patents, primarily in Cytokine Inhibitors. Top assignees: Smithkline Beecham Corporation, Beecham Group Plc, Beecham Pharmaceuticals (Pte) Limited. Active years: 1980-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laramie Mary Gaster. Retrieved from https://idiyas.com/inventor/laramie-mary-gaster

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 95.8

Average Co-Inventor Count = 2.4

ph-index = 12

Forward Citations = 420(Granted Patents)


Location History:

  • Sawbridgeworth, GB (1980 - 1984)
  • Bishop Stortford, GB (1986)
  • Bishops Stortfield, GB (1998)
  • Bishop's Stortford, GB (1985 - 2003)
  • Harlow, GB (1991 - 2005)

Company Filing History:


Years Active: 1980-2005

Loading Chart...
Areas of Expertise:
Cytokine Inhibitors
5-HT Receptor Antagonists
Indole Derivatives
Bicyclic Compounds
Spiro Compounds
Heterocyclic Compounds
Amide Derivatives
Tetracyclic Compounds
Tricyclic Compounds
Biphenyl Compounds
Pharmaceuticals
48 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Laramie Mary Gaster

Introduction:

Laramie Mary Gaster, a prolific inventor hailing from Bishop's Stortford, GB, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 48 patents to his name. His innovative work has led to the development of novel compounds with therapeutic applications, earning him recognition in the industry.

Latest Patents:

Among Gaster's latest patents is the groundbreaking invention of Triarylimidazole derivatives as cytokine inhibitors, represented by compounds of formula (I) or a pharmaceutically acceptable salt thereof. Additionally, he has pioneered the development of Indole derivatives as 5-HT receptor antagonists, which hold promise in the treatment of central nervous system disorders such as anxiety.

Career Highlights:

Having worked with esteemed companies such as SmithKline Beecham Corporation and Beecham Group Plc, Gaster has honed his expertise in the pharmaceutical sector. His innovative mindset and dedication to research have been instrumental in driving advancements in drug discovery and development, setting him apart as a trailblazer in the field.

Collaborations:

Throughout his career, Gaster has collaborated with talented individuals such as Paul Adrian Wyman and Francis D King, pooling their collective knowledge and expertise to push the boundaries of pharmaceutical innovation. These collaborations have played a crucial role in translating pioneering ideas into tangible inventions that benefit society.

Conclusion:

In conclusion, Laramie Mary Gaster's remarkable journey as an inventor epitomizes the spirit of innovation and perseverance. His numerous patents and collaborative efforts underscore his commitment to advancing the field of pharmaceuticals, leaving a lasting impact on the industry. Gaster's contributions serve as an inspiration to aspiring inventors and researchers, showcasing the transformative power of ingenuity and dedication in driving progress and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…